All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 87 of 206 pages ‹ First < 85 86 87 88 89 > Last ›
HSL9407
Waxman lashes DTC advertisers
Medical Marketiing and Media 2007 Apr 11
http://www.mmm-online.com/content/index.php?id=28&tx_ttnews[tt_news]=12513&tx_ttnews[backPid]=11&cHash=a800819fa6
HSL9340
Saul S.
Celebrex Commercial, Long and Unconventional, Draws Criticism
New York Times 2007 Apr 10
http://www.nytimes.com/2007/04/10/business/media/10celebrex.html?_r=1&ref=business&oref=slogin
HSL9356
Perrone M.
Wall Street Does Not Expect Blockbuster U.S. Sales From Merck's Vioxx Follow-Up, Arcoxia
Associated Press 2007 Apr 10
http://biz.yahoo.com/ap/070410/fda_arcoxia.html?.v=2
HSL9357
Steyer R.
FDA Cautious on Pain Drugs
TheStreet.com 2007 Apr 10
http://www.thestreet.com/_yahoo/newsanalysis/pharmaceuticals/10349416_3.html
HSL10001
Meador KJ.
How skeptical should we be about industry-sponsored studies?
Neurology 2007 Apr 10;68:(15):1238
http://www.neurology.org/cgi/content/full/68/15/1238
HSL9341
Wolfe SM.
Public Citizen calls on FDA to stop illegal Celebrex television advertisement
Public Citizen 2007 Apr 9
http://www.citizen.org/hot_issues/issue.cfm?ID=1577
HSL11713
Pham HH, Alexander GC, O'Malley AS.
Physician consideration of patients' out-of-pocket costs in making common clinical decisions.
Arch Intern Med 2007 Apr 9;167:(7):663-8
http://archinte.ama-assn.org/cgi/content/full/167/7/663
HSL12354
Fineberg HV.
Reinventing the US Food and Drug Administration.
MedGenMed 2007 Apr 9;9:(2):6
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17955063
HSL9264
Swiatek J.
Ruling to Benefit Plaintiffs in Zyprexa Suits
The Indianapolis Star 2007 Apr 7
http://www.redorbit.com/news/health/462914/ruling_to_benefit_plaintiffs_in_zyprexa_suits/index.html
HSL9285
Dowie J.
Transparency in NICE
BMJ 2007 Apr 7;334:(7596):709
http://www.bmj.com/cgi/content/full/334/7596/709-a
HSL9286
Tuffs A.
German doctors protest about firm offering fetal sex tests in early pregnancy
BMJ 2007 Apr 7;334:(7596):712
http://www.bmj.com/cgi/content/full/334/7596/712
HSL9287
Kmietowicz Z.
MMR controversy has left parents emotionally scarred, study finds
BMJ 2007 Apr 7;334:(7596):715
http://www.bmj.com/cgi/content/full/334/7596/715-d
HSL9288
Gornall J.
Duplicate publication: a bitter dispute
BMJ 2007 Apr 7;334:(7596):717
http://www.bmj.com/cgi/content/full/334/7596/717
HSL9289
Coombes R.
Human papillomavirus vaccine: Life saving treatment or giant experiment?
BMJ 2007 Apr 7;334:(7596):721-723
http://www.bmj.com/cgi/content/full/334/7596/721
HSL9350
Pear R.
Congress Seeks Compromise on Generic Drugs
New York Times 2007 Apr 7
http://www.nytimes.com/2007/04/08/washington/08drug.html?_r=1&em&ex=1176177600&en=dc6671ca66f46bbd&ei=5087%0A&oref=slogin
HSL9808
Weatherall D.
Animal research: the debate continues.
Lancet 2007 Apr 7;369:(9568):1147-8
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17416244&query_hl=6&itool=pubmed_DocSum
HSL9265
Ginsberg T.
Astra sales manager fired over his comments in a newsletter
The Philadelphia Inquirer 2007 Apr 6
http://www.philly.com/inquirer/breaking/business_breaking/20070406_Astra_sales_manager_fired_over_his_comments_in_a_newsletter.html
HSL9266
Hutchinson M.
Busting modern medical myths
BBC News 2007 Apr 6
http://news.bbc.co.uk/2/hi/health/6524865.stm
HSL9263
Groppe M.
Senator to Lilly: Turn over Zyprexa files
Indianapolis Star 2007 Apr 5
http://www.indystar.com/apps/pbcs.dll/article?AID=/20070405/BUSINESS/704050483/-1/ZONES04
HSL9267
Hensley S.
Pharma Box Office: Sales Force Shifts
Wall Street Journal Health Blog 2007 Apr 5
http://blogs.wsj.com/health/2007/04/05/pharma-box-office-sales-force-shifts/
HSL9268
Reuters .
Experts: New Merck drug won't get OK
CNNMoney.com 2007 Apr 5
http://www.royalsociety.org.nz/2007/04/06/merck-arcoxia/
HSL9269
Kennedy VB.
Biotech, pharma gain; Wyeth rises on FDA update
MarketWatch 2007 Apr 5
http://www.marketwatch.com/news/story/biotech-pharma-stocks-gain-wyeth/story.aspx?guid=%7B93F48B82-F2AE-4DCB-9672-8B3B1D4A7FE8%7D&siteid=yhoo&dist=yhoo
HSL9270
Perrone M.
Senator Probes Eli Lilly Drug Promotion
Associated Press 2007 Apr 5
http://biz.yahoo.com/ap/070405/eli_lilly_grassley_letter.html?.v=3
HSL9271
Pringle E.
April 2007 Big Pharma Litigation Update - Drugs Part I
Lawyers and Settlements 2007 Apr 5
http://www.lawyersandsettlements.com/articles/00723/big-pharma-1.html
HSL9281
Mathew JC.
Patent board to hear Novartis` Gleevac case
Business Standard (Mumbai) 2007 Apr 5
http://web.archive.org/web/20070510065427/http://www.business-standard.com/common/storypage.php?autono=280112&leftnm=3&subLeft=0&chkFlg=
HSL9282
Pringle E.
Drug Companies Want Women Of Childbearing Years
Countercurrents.org 2007 Apr 5
http://www.countercurrents.org/pringle050407.htm
HSL9351
Harvey K.
Schwabe Pharma Australia & Natural Health Products - litigation update
AusPharmList (subscription required) 2007 Apr 5
http://www.auspharmlist.net.au/post.php?postid=9858
HSL9365
Vaidyanath S.
Does Canada Need a HPV Vaccine?
The Epoch Times 2007 Apr 5
http://en.epochtimes.com/news/7-4-5/53785.html
HSL9368
Pharmaceutical Industry Spends Record $155M Lobbying Federal Government From 2005 Through First Half Of 2006, Study Finds
Medical News Today 2007 Apr 5
http://www.medicalnewstoday.com/medicalnews.php?newsid=67058
HSL10117
Rost P.
AstraZeneca: "There is a big bucket of money sitting in every [doctor's] office"
Question Authority (Blog) 2007 Apr 5
http://peterrost.blogspot.com/2007/04/astrazeneca-there-is-big-bucket-of.html
HSL9123
Smith A.
Pity the poor pharmaceutical sales rep
CNNMoney.com 2007 Apr 4
http://money.cnn.com/2007/04/02/news/companies/drug_rep/index.htm?source=yahoo_quote
HSL9124
Rost P.
Little More than a Speeding Ticket: Pfizer's $35 Million Fine
Counterpunch 2007 Apr 4
http://www.counterpunch.org/rost04042007.html
HSL9130
Lee D.
Lilly faces Zyprexa suit from investors
Indianapolis Star 2007 Apr 4
http://www.indystar.com/apps/pbcs.dll/article?AID=/20070404/BUSINESS/704040437/1003/BUSINESS
HSL9131
Murphy T.
Lilly shareholders sue over anti-psychotic drug Zyprexa
Canadian Press 2007 Apr 4
http://www.canada.com/topics/technology/news/gizmos/story.html?id=879871d2-ea35-4061-9d21-61623b155614&k=66922
HSL9135
Goldstein S.
Pfizer's British distribution pact to be probed
Market Watch 2007 Apr 4
http://www.marketwatch.com/news/story/pfizers-uk-distribution-pact-probed/story.aspx?guid=%7B40865B2F%2D68EC%2D4C1B%2D8CB4%2DB1128F645482%7D&siteid=yhoo&dist=yhoo
HSL9280
Lawler B.
Novartis Gets Nicked
The Motley Fool 2007 Apr 4
http://www.fool.com/investing/general/2007/04/04/novartis-gets-nicked.aspx
HSL9290
Goldstein J.
Hormones for Menopause Get Reprieve
Wall Street Journal Health Blog 2007 Apr 4
http://blogs.wsj.com/health/2007/04/04/hormones-for-menopause-get-reprieve/
HSL9291
Goldstein J.
A Measure of Vindication for Wyeth
Wall Street Journal Health Blog 2007 Apr 4
http://blogs.wsj.com/health/2007/04/04/a-measure-of-vindication-for-wyeth/
HSL9292
Parker-pope T.
New Study Reassures Most Users of Hormones
Wall Street Journal 2007 Apr 4A1
http://online.wsj.com/google_login.html?url=http%3A%2F%2Fonline.wsj.com%2Farticle%2FSB117564478980559031.html%3Fmod%3Dgooglenews_wsj
HSL9119
Bristol-Myers Says FTC Seeks Files on Apotex Deal
Reuters 2007 Apr 3
http://investing.reuters.co.uk/news/articleinvesting.aspx?type=health&storyID=2007-04-03T170208Z_01_WEN6048_RTRIDST_0_SP_PAGE_015-WEN6048-OISHE.XML
HSL9127
Alonso-zaldivar R .
Drug makers set lobbying record
Los Angeles Times 2007 Apr 3
http://articles.latimes.com/2007/apr/03/nation/na-lobby3
HSL9133
Bristol-Myers Gets FTC Document Request
Associated Press 2007 Apr 3
http://biz.yahoo.com/ap/070403/bristol_myers_squibb_ftc.html?.v=2
HSL9284
Pfizer Unit Pleads Guilty, Prosecutors Praise the Corporate Criminal, Not the Whistleblower
Corporate Crime Reporter 2007 Apr 3
http://www.corporatecrimereporter.com/pfizer040307.htm
HSL9110
Senator the Hon Brett Mason - Parliamentary Secretary to the Minister for Health and Ageing
New therapeutic products exposure Bill released
Commonwealth of Australia Department of Health and Ageing 2007 Apr 2
http://www.health.gov.au/internet/ministers/publishing.nsf/Content/mr-yr07-cp-mas003.htm
HSL9114
Herper M.
Celebrex Ads To Return
Forbes.com 2007 Apr 2
http://www.forbes.com/2007/04/01/pfizer-arthritis-vioxx-biz-sci-cz_mh_0402celebrex.html?partner=yahootix
HSL9115
Soule A.
Feds join suit against Boehringer Ingelheim
Fairfield County Business Journal 2007 Apr 2
http://www.fairfieldcbj.com/archive/040207/0402070002.php
HSL9118
Vedantam S.
Criteria for Depression Are Too Broad, Researchers Say
Washington Post 2007 Apr 2A02
http://www.washingtonpost.com/wp-dyn/content/article/2007/04/02/AR2007040201693.html
HSL9120
Pierson R.
Pfizer to pay $35 mln in Genotropin settlements
Reuters 2007 Apr 2
http://www.reuters.com/article/health-SP/idUSWNAS544720070402
HSL9122
Rubin R.
Pfizer enlists doctors to defend Lipitor
USA Today 2007 Apr 2
http://www.usatoday.com/news/health/2007-04-02-pfizer-lipitor_N.htm
HSL9126
Edwards J, Ebenkamp B.
FTC May Go After Celeb Endorsements
Brandweek 2007 Apr 2
http://www.brandweek.com/bw/news/packaged/article_display.jsp?vnu_content_id=1003566021
HSL9262
Ferreira-Gonzalez I, Busse JW, Heels-Ansdell D, Montori VM, Akl EA, Bryant DM, Alonso-Coello P, Alonso J, Worster A, Upadhye S, Jaeschke R, Schunemann HJ, Permanyer-Miralda G, Pacheco-Huergo V, Domingo-Salvany A, Wu P, Mills EJ, Guyatt GH.
Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials.
BMJ 2007 Apr 2;
http://www.bmj.com/cgi/rapidpdf/bmj.39136.682083.AEv1?eaf
HSL9283
Lavoie D.
Pfizer subsidiaries agree to pay $34.7M
Associated Press 2007 Apr 2
http://www.abcmoney.co.uk/news/02200749968.htm
HSL9855
Hensley S.
Pfizer’s Kindler Speaks, Briefly
The Wall Street Journal Health Blog 2007 Apr 2
http://blogs.wsj.com/health/2007/04/02/pfizers-kindler-speaks-briefly/?mod=yahoo_hs
HSL10077
Cheng AC, Robinson PM, Harvey K.
Off-label use of medicines: consensus recommendations for evaluating appropriateness.
Med J Aust 2007 Apr 2;186:(7):379-80
http://www.mja.com.au/public/issues/186_07_020407/letters_020407_fm-2.html
HSL9113
Kroft S.
Under The Influence
CBS News 2007 Apr 1
http://www.cbsnews.com/stories/2007/03/29/60minutes/main2625305.shtml
HSL9117
Price JH.
Spending on psychotherapeutic drugs soars
The Washington Times 2007 Apr 1
http://www.washingtontimes.com/national/20070401-120128-5227r.htm
HSL9121
Schmit J.
Pfizer to resume airing ads for Celebrex
USA Today 2007 Apr 1
http://www.usatoday.com/money/industries/health/drugs/2007-04-01-celebrex-usat_N.htm?csp=34
HSL9279
Brownlee S.
Feeding the Cancer Machine
New York Times 2007 Apr 1
http://www.nytimes.com/2007/04/01/opinion/01brownlee.html?ex=1176177600&en=7bc65522b5b5a8df&ei=5070
HSL9809
Abel GA, Lee SJ, Weeks JC.
Direct-to-consumer advertising in oncology: a content analysis of print media.
J Clin Oncol 2007 Apr 1;25:(10):1267-71
http://jco.ascopubs.org/cgi/content/full/25/10/1267
HSL10078
Young D.
Regulators, groups engage in user fee debate.
Am J Health Syst Pharm 2007 Apr 1;64:(7):684,
http://www.ajhp.org/cgi/content/full/64/7/684
HSL11460
Arguello B, Fernandez-Llimos F.
[Professionals' access to drug package inserts].
Aten Primaria 2007 Apr 1;39:(4):219
http://www.doyma.es/cgi-bin/wdbcgi.exe/doyma/mrevista.fulltext?pident=13100849
HSL8677
Littman BH, Di Mario L, Plebani M, Marincola FM.
What's next in translational medicine?
Clin Sci (Lond) 2007 Apr;112:(4):217-27
http://www.clinsci.org/cs/112/0217/cs1120217.htm
HSL9128
Gallagher R.
Companies, You're on Notice
The Scientist 2007 Apr
http://www.the-scientist.com/article/home/52948/
HSL9132
Cassels A.
Defying your drug regimen - the do's and dont's
Common Ground 2007 Apr
http://commonground.ca/iss/0704189/cg189_drugs.shtml
HSL9166
Nemeroff CB, Kalali A, Keller MB, Charney DS, Lenderts SE, Cascade EF, Stephenson H, Schatzberg AF.
Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
Arch Gen Psychiatry 2007 Apr;64:(4):466-72
http://archpsyc.ama-assn.org/cgi/content/full/64/4/466
HSL9172
Mackenzie FJ, Jordens CF, Ankeny RA, McPhee J, Kerridge IH.
Direct-to-consumer advertising under the radar: the need for realistic drugs policy in Australia.
Intern Med J 2007 Apr;37:(4):224-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2006.01298.x
HSL9360
Singer E.
Aggressive drug marketing tactics trigger backlash.
Nat Med 2007 Apr;13:(4):393
http://www.nature.com/doifinder/10.1038/nm0407-393
HSL10003
Shankar PR, Subish P.
Disease mongering.
Singapore Med J 2007 Apr;48:(4):275-80
http://smj.sma.org.sg/4804/4804ra1.pdf
HSL10016
Strauss JF 3rd, Chaudhuri G.
The accelerated pace of pharma abandonment of research and development in family planning and fertility: will reproductive health technology be frozen in time?
Fertil Steril 2007 Apr;87:(4):717-8
http://linkinghub.elsevier.com/retrieve/pii/S0015-0282(06)04382-2
HSL10017
Cras A, Conscience MA, Rajzbaum G, Lillo-Le Louet A, Lopez N, Tersen I, Bezie Y.
Off-label prescribing in a French hospital.
Pharm World Sci 2007 Apr;29:(2):97-100
http://www.springerlink.com/content/h677674tk8x48572/
HSL10073
Chapman K, Kelly B, King L, Flood V.
Fat chance for Mr Vegie TV ads.
Aust N Z J Public Health 2007 Apr;31:(2):190
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17461013&query_hl=6&itool=pubmed_DocSum
HSL10074
Mitchell P.
Price controls seen as key to Europe's drug innovations lag.
Nat Rev Drug Discov 2007 Apr;6:(4):257-8
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17457995&query_hl=7&itool=pubmed_DocSum
HSL10075
[No authors listed].
The pricing conundrum.
Nat Rev Drug Discov 2007 Apr;6:(4):255
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17457994&query_hl=8&itool=pubmed_DocSum
HSL10082
Weiskopf RB; Novo Nordisk.
Food and Drug Administration public hearing on the draft guidance for exception from informed consent requirements for emergency research: testimony of Novo Nordisk.
Acad Emerg Med 2007 Apr;14:(4):e71-3
http://www.aemj.org/cgi/content/full/14/4/e71
HSL10122
Pruss A, von Versen R.
[Influence of European Regulations on Quality, Safety and Availibility of Cell and Tissue Allografts in Germany.]
Handchir Mikrochir Plast Chir 2007 Apr;39:(2):81-87
http://www.thieme-connect.com/DOI/DOI?10.1055/s-2007-965134
HSL10129
[No authors listed]
Arterial 'prehypertension': a useful concept for drug companies, useless for patients
Prescrire Int. 2007 Apr;16:(88):73-5
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17460859&query_hl=2&itool=pubmed_DocSum
HSL10133
Gressens P.
Drug companies and neuroprotection of the newborn: any hope for a love story?
Acta Paediatr 2007 Apr;96:(4):485-6
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1651-2227.2007.00265.x
HSL10134
The Lancet Infectious Diseases.
Tackling negative perceptions towards vaccination.
Lancet Infect Dis 2007 Apr;7:(4):235
http://linkinghub.elsevier.com/retrieve/pii/S1473-3099(07)70057-9
HSL10136
Adeoye S, Bozic KJ.
Direct to consumer advertising in healthcare: history, benefits, and concerns.
Clin Orthop Relat Res 2007 Apr;457:96-104:
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?doi=10.1097/BLO.0b013e31803427e6
HSL10137
Cunningham MR, Warme WJ, Schaad DC, Wolf FM, Leopold SS.
Industry-funded positive studies not associated with better design or larger size.
Clin Orthop Relat Res 2007 Apr;457:235-41:
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?doi=10.1097/BLO.0b013e3180312057
HSL10156
Staff of the Committee on Finance
Use of Educational Grants by Pharmaceutical Manufacturers
Washington, DC: United States Senate 2007 Apr
http://web.archive.org/web/20110111193718/http://www.acme-assn.org/home/prb042507a.pdf
HSL10203
Jommi C, Paruzzolo S.
Public administration and R&D localisation by pharmaceutical and biotech companies: a theoretical framework and the Italian case-study.
Health Policy 2007 Apr;81:(1):117-30
http://linkinghub.elsevier.com/retrieve/pii/S0168-8510(06)00112-6
HSL10556
Hansen DG, Dybdahl T, Jarbol D, Vach W.
Clinical interest: a study of the influence on general practitioners' prescribing.
Pharmacoepidemiol Drug Saf 2007 Apr;16:(4):458-63
http://www3.interscience.wiley.com/cgi-bin/abstract/114113712/ABSTRACT?CRETRY=1&SRETRY=0
HSL10569
Borders JM.
Physicians and pharma--an unholy alliance?
J Ky Med Assoc 2007 Apr;105:(4):177-8
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17494281&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL10579
Croft AM.
A lesson learnt: the rise and fall of Lariam and Halfan.
J R Soc Med 2007 Apr;100:(4):170-4
http://www.jrsm.org/cgi/content/full/100/4/170
HSL10580
Tormala ZL, Clarkson JJ.
Assimilation and contrast in persuasion: the effects of source credibility in multiple message situations.
Pers Soc Psychol Bull 2007 Apr;33:(4):559-71
http://psp.sagepub.com/cgi/reprint/33/4/559
HSL10692
Acharya S.
Ethical issues in research outsourcing.
J Dent Educ 2007 Apr;71:(4):447-8
http://www.jdentaled.org/cgi/content/full/71/4/447
HSL10695
Wayman JJ, Beall T, Thackeray R, Brown KR.
Competition: a social marketer's friend or foe?
Health Promot Pract 2007 Apr;8:(2):134-9
http://hpp.sagepub.com/cgi/reprint/8/2/134
HSL10696
Goldman KD, Schmalz KJ.
Speech righting: presentation preparation principles for potent performances.
Health Promot Pract 2007 Apr;8:(2):114-8
http://hpp.sagepub.com/cgi/reprint/8/2/114
HSL10697
Cambronero-Saiz B.
Pharmaceutical advertising: from prospectus to marketing.
J Epidemiol Community Health 2007 Apr;61:(4):366
http://jech.bmj.com/cgi/content/full/61/4/366
HSL10778
Webster CS, Merry AF.
Colour coding, drug administration error and the systems approach to safety.
Eur J Anaesthesiol 2007 Apr;24:(4):385-6
http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=522248
HSL10818
Giri BR, Shankar RP.
Disease mongers in a nation in transition?
Rural Remote Health 2007 Apr-Jun;7:(2):621
http://www.rrh.org.au/articles/subviewnew.asp?ArticleID=621
HSL10820
Shankar RP.
Being a dispensing prescriber in rural South India.
Rural Remote Health 2007 Apr-Jun;7:(2):717
http://www.rrh.org.au/articles/subviewnew.asp?ArticleID=717
HSL10822
Clover J, Wall J.
Marketing ideas and strategies for building upon the team physician's role.
Clin Sports Med 2007 Apr;26:(2):253-63
http://linkinghub.elsevier.com/retrieve/pii/S0278-5919(07)00007-5
HSL10828
Sams-Dodd F.
Research & market strategy: how choice of drug discovery approach can affect market position.
Drug Discov Today 2007 Apr;12:(7-8):314-8
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T64-4N6NHP5-2&_user=10&_coverDate=04%2F30%2F2007&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=e90f57a4ce208ef3406bbb26d8556bc4
HSL10829
Proceedings of TCT: TCT Keynote Speaker Addresses conflict of interest.
J Interv Cardiol 2007 Apr;20:(2):171-2
HSL10901
Jin CH, Villegas J.
Consumer responses to advertising on the Internet: the effect of individual difference on ambivalence and avoidance.
Cyberpsychol Behav 2007 Apr;10:(2):258-66
http://www.liebertonline.com/doi/abs/10.1089/cpb.2006.9960
HSL10902
Cave S.
Corruption in health services.
J Health Serv Res Policy 2007 Apr;12:(2):67-8
http://jhsrp.rsmjournals.com/content/12/2/67.full.pdf+html
HSL10903
Segal JZ.
lIlness as argumentation: a prolegomenon to the rhetorical study of contestable complaints.
Health (London) 2007 Apr;11:(2):227-44
http://hea.sagepub.com/cgi/reprint/11/2/227
HSL10953
Hart D.
Patient information on drug therapy. A problem of medical malpractice law: between product safety and user safety.
Eur J Health Law 2007 Apr;14:(1):47-59
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17566320&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Page 87 of 206 pages ‹ First < 85 86 87 88 89 > Last ›
